Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas

Archives of Gynecology and Obstetrics

Volumn 271, Issue 2, 2005, Pages 104-108

  Boran, Nurettin ^a   Tulunay, Gökhan ^a   Caliskan, Eray ^a   Köse, M Faruk ^a   Haberal, Ali ^a  

^a SSK Ankara Matern Women's Hlth T   (Turkey)

Author keywords

Dysgerminoma; Ovary; Pregnancy

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADJUVANT CHEMOTHERAPY; ANENCEPHALUS; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CURETTAGE; DYSGERMINOMA; FEMALE; FERTILITY; HUMAN; MENSTRUAL CYCLE; NULLIPARA; PREGNANCY; PREGNANCY COMPLICATION; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR DIAGNOSIS;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; DYSGERMINOMA; FEMALE; FERTILITY; HUMANS; MENSTRUATION; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 16444372630     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-004-0601-6     Document Type: Article

References (22)

1. Bakri YN, Ezzat A, Akhtar, Dohami, Zahrani (2000) Malignant germ cell tumors of the ovary: pregnancy considerations. Eur J Obstet Gynecol 90:87-91
2. Brewer M, Gershenson DM, Herzog CE, Mitchell MF, Silva EG, Wharton JT (1999) Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol 17:2670-2675
3. Bridgewater JA, Rustin GJS (1999) Management of non-epithelial ovarian tumors. Oncology 57:89-98
4. Casey AC, Bhodauria S, Shapter A, Nieberg R, Berek JS, Farias-Eisner R (1996) Dysgerminoma: the role of conservative surgery. Gynecol Oncol 63:352-357
5. Culine S, Lhomme C, Kattan J, Duvillard P, Michel G, Gerbaulet A, Droz J-P (1995) Cisplatin-based chemotherapy in dysgerminoma of the ovary: thirteen year experience at the Institute Gustave Roussy. Gynecol Oncol 58:344-348
6. Dark GG, Bower M, Newlands ES, Paradinas F, Rustin GJS (1997) Surveillance policy for stage I ovarian germ cell tumors. J Clin Oncol 15:620-624
7. Dimopoulos MA, Papadopoulou M, Andreopoulou E, Papadimitriou C, Pavlidis N, Aravantinos G et al (1998) Favorable outcome of ovarian malignancies treated with cisplatin or carboplatin based chemotherapy: a Hellenic Cooperative Oncology Group Study. Gynecol Oncol 70:70-74
8. Ezzat A, Raja M, Bakri Y, Subhi J, Schwartz P et al (1999) Malignant ovarian germ cell tumors: a survival and prognostic analysis. Acta Oncol 38:455-460
9. FIGO Cancer Committee (1986) Staging announcement. Gynecol Oncol 25:383
10. Gershenson DM (1988) Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol 6:270-275
11. Gershenson DM, Wharton T, Kline RC, Larson DM, Kavanagh JJ, Rutledge FN (1986) Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma: potential for cure and preservation of reproduction capacity. Cancer 58:2594-2599
12. Gershenson DM, Morris M, Cangir A, Kavanagh JJ, Stringer CA, Edwards CL et al (1990) Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide and cisplatin. J Clin Oncol 8:715-720
13. Jacobs AJ, Harris M, Deppe G, DasGupta I, Cohen CJ (1982) Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine and bleomycin. Obstet Gynecol 59:129-132
14. Kurman RJ, Norris HJ (1977) Malignant germ cell tumors of the ovary. Hum Pathol 8:551-564
15. Mitchell MF, Gershenson DM, Soeters RP, Eifel PJ, Delclos L, Wharton JT (1991) The long term effects of radiotherapy on patients with ovarian dysgerminoma. Cancer 67:1084-1090
16. Schwartz PE (1984) Combination chemotherapy in the management of ovarian germ cell malignancies. Obstet Gynecol 64:564-572
17. Slayton RE, Park RC, Silverberg SG, Shingleton H, Creasman WT, Blessing JA (1985) Vincristine, dactinomycine and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary: a Gynecologic Oncology Group Study. Cancer 56:243-248
18. Stanton G, Bosl G, Whitmore WC (1985) VAB-6 as initial treatment of patients with advanced seminoma. J Clin Oncol 3:336-339
19. Tewari K (2000) Malignant germ cell tumors of the ovary. Obstet Gynecol 95:128-133
20. Thomas GM, Dembo A, Hacker NF, DePetrillo AD (1987) Current therapy for dysgerminoma of the ovary. Obstet Gynecol 70:268-275
21. Williams SD, Blessing JA, Moore DH, Homesley HD, Adcock L (1989) Cisplatin, vinblastine and bleomycin in advanced and recurrent ovarian germ cell tumors. Ann Intern Med 111:22-27
22. Williams SD, Blessing JA, Hatch KD, Homesley HD (1991) Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group. J Clin Oncol 9:1950-1955